|
⚲
|
| Keyboard |
| ISIS Pharmaceuticals Inc | |
|---|---|
| Ticker | IONS |
| CIK # | 0000874015 |
| CUSIP | 462222100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1896 Rutherford Road, Carlsbad, CA 92008 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| ISIS Pharmaceuticals Inc | 2012-08-27 | 201.2 M | Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0000874015] | 10-K | |
| [0000874015] | 10-Q | |
| [0000874015] | 3 | |
| [0000874015] | 4 | |
| [0000874015] | 5 | |
| [0000874015] | 8-K | |
| [0000874015] | D | |
| [0000874015] | SC 13D | |
| [0000874015] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Schneider Eugene
Common Stock
|
2026-03-19 | Sell | 5,812 | $70.97 | 412,478 |
|
Hougen Elizabeth L
Common Stock
|
2026-03-17 | Sell | 10,172 | $73.21 | 744,692 |
|
Hougen Elizabeth L
Common Stock
|
2026-03-16 | Option exercise | 61,041 | $56.78 | 3,465,908 |
|
Hougen Elizabeth L
Common Stock
|
2026-03-16 | Option exercise | 60,299 | $60.89 | 3,671,606 |
|
Hougen Elizabeth L
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-16 | Option exercise | 60,299 | $0.00 | |
|
Hougen Elizabeth L
Common Stock
|
2026-03-16 | Option exercise | 20,541 | $37.58 | 771,931 |
|
Hougen Elizabeth L
Common Stock
|
2026-03-16 | Sell | 9,440 | $72.77 | 686,949 |
|
Hougen Elizabeth L
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-16 | Option exercise | 20,541 | $0.00 | |
|
Hougen Elizabeth L
Common Stock
|
2026-03-16 | Option exercise | 33,118 | $32.60 | 1,079,647 |
|
Hougen Elizabeth L
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-16 | Option exercise | 61,041 | $0.00 | |
|
Hougen Elizabeth L
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-16 | Option exercise | 33,118 | $0.00 | |
|
Hougen Elizabeth L
Common Stock
|
2026-03-16 | Sell | 205,608 | $72.38 | 14,881,907 |
|
Jenne Kyle
Common Stock
|
2026-03-10 | Option exercise | 4,675 | $34.69 | 162,176 |
|
Jenne Kyle
Common Stock
|
2026-03-10 | Sell | 21,191 | $75.50 | 1,599,920 |
|
Jenne Kyle
Common Stock
|
2026-03-10 | Sell | 16,086 | $76.30 | 1,227,362 |
|
Jenne Kyle
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-10 | Option exercise | 4,675 | $0.00 | |
|
Monia Brett P
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-10 | Option exercise | 34,103 | $0.00 | |
|
Monia Brett P
Common Stock
|
2026-03-10 | Sell | 17,591 | $76.34 | 1,342,897 |
|
Jenne Kyle
Common Stock
|
2026-03-10 | Option exercise | 32,602 | $46.10 | 1,502,952 |
|
Jenne Kyle
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-10 | Option exercise | 32,602 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 497 | 164,810,872 |
| 2025-12-31 | 499 | 158,387,337 |
| 2025-09-30 | 446 | 154,076,921 |
| 2025-06-30 | 369 | 150,834,338 |
| 2025-03-31 | 351 | 147,207,981 |
| 2024-12-31 | 362 | 142,662,455 |
| 2024-09-30 | 358 | 140,068,716 |
| 2024-06-30 | 360 | 129,434,535 |
| 2024-03-31 | 363 | 128,650,976 |
| 2023-12-31 | 368 | 127,836,407 |
| 2023-09-30 | 316 | 123,404,611 |
| 2023-06-30 | 310 | 119,425,744 |